Dysbiosis and impaired gastrointestinal barrier function have emerged as potential chronic
kidney disease (CKD) modulators. Accumulation of gut-derived uremic toxins, a subsequent …

Background and Objectives: Chronic inflammation due to Pseudomonas aeruginosa (PA)
infection in people with cystic fibrosis (CF) remains a concerning issue in the wake of …

Objectives Fibroblast growth factor 23 (FGF23) plays a key role in the pathophysiology of
chronic kidney disease (CKD) and of the associated cardiovascular diseases, ranking on the …

Chronic kidney disease mineral bone disorder (CKD-MBD) is a virtually universal
complication of kidney diseases, starting early in the course of disease and resulting in …

Background: Inorganic phosphate (Pi) binders are the only pharmacologic treatment
approved for hyperphosphatemia. However, Pi binders induce the expression of intestinal Pi …

Chronic kidney disease (CKD) is a clinical syndrome characterized by persistent renal
function decline. Renal fibrosis is the main pathological process in CKD, but an effective …

Introduction X-linked hypophosphatemia (XLH) is caused by an inactivating mutation in the
phosphate-regulating endopeptidase X-linked (PHEX) gene whose defective product fails to …

Chronic kidney disease (CKD) affects> 10% of the global adult population and significantly
increases the risk of cardiovascular disease (CVD), which remains the leading cause of …

Dietary phosphorus oversupply wastes non-renewable natural resources and raises
environmental concerns in animal agriculture. We hypothesized that laying hens do not …

Modern intravenous iron compounds (eg, ferric carboxymaltose [FCM] and ferric
derisomaltose [FDI]) are utilized in the treatment of iron deficiency anemia in non-dialysis …